LARP1 post-transcriptionally regulates mTOR and contributes to cancer progression

Oncogene

Volumn 34, Issue 39, 2015, Pages 5025-5036

  Mura, M ^a   Hopkins, T G ^a   Michael, T ^a   Abd Latip, N ^a   Weir, J ^b   Aboagye, E ^c   Mauri, F ^a   Jameson, C ^d   Sturge, J ^c,e   Gabra, H ^a   Bushell, M ^f   Willis, A E ^f   Curry, E ^a   Blagden, S P ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b CHARING CROSS HOSPITAL   (United Kingdom)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

^e UNIVERSITY OF HULL   (United Kingdom)

^f UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LARP1 PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MEMBRANE PROTEIN; MESSENGER RNA; UNCLASSIFIED DRUG; AUTOANTIGEN; MTOR PROTEIN, HUMAN; RIBONUCLEOPROTEIN; SS-B ANTIGEN; TARGET OF RAPAMYCIN KINASE;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; FEMALE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; IN VIVO STUDY; MOUSE; NON SMALL CELL LUNG CANCER; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; RNA PROCESSING; UTERINE CERVIX CANCER; ANIMAL; BAGG ALBINO MOUSE; DISEASE COURSE; GENETICS; METASTASIS; NEOPLASM; PATHOLOGY; PHYSIOLOGY; TUMOR INVASION;

ANIMALS; AUTOANTIGENS; DISEASE PROGRESSION; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; RIBONUCLEOPROTEINS; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER; TOR SERINE-THREONINE KINASES;

EID: 84942549961     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2014.428     Document Type: Article

References (46)

1. Wu X, Brewer G. The regulation of mRNA stability in mammalian cells: 2.0. Gene 2012; 500: 10-21.
2. Sugiura R, Satoh R, Ishiwata S, Umeda N, Kita A. Role of RNA-binding proteins in MAPK signal transduction pathway. J Signal Transduct 2011; 2011: 109746.
3. Thapar R, Denmon AP. Signaling pathways that control mRNA turnover. Cell Signal 2013; 25: 1699-1710.
4. Keene JD, Lager PJ. Post-transcriptional operons and regulons co-ordinating gene expression. Chromosome Res 2005; 13: 327-337.
5. Blagden SP, Willis AE. The biological and therapeutic relevance of mRNA translation in cancer. Nat Rev Clin Oncol 2011; 8: 280-291.
6. Castello A, Fischer B, Eichelbaum K, Horos R, Beckmann BM, Strein C et al. Insights into RNA biology from an atlas of mammalian mRNA-binding proteins. Cell 2012; 149: 1393-1406.
7. Xie C, Huang L, Xie S, Xie D, Zhang G, Wang P et al. LARP1 predict the prognosis for early-stage and AFP-normal hepatocellular carcinoma. J Transl Med 2013; 11: 272.
8. Sommer G, Dittmann J, Kuehnert J, Reumann K, Schwartz PE, Will H et al. The RNAbinding protein La contributes to cell proliferation and CCND1 expression. Oncogene 2011; 30: 434-444.
9. Staudacher AH, Al-Ejeh F, Fraser CK, Darby JM, Roder DM, Ruszkiewicz A et al. The La antigen is over-expressed in lung cancer and is a selective dead cancer cell target for radioimmunotherapy using the La-specific antibody APOMAB(R). EJNMMI Res 2014; 4: 2.
10. Biewenga P, Buist MR, Moerland PD, Ver Loren van Themaat E, van Kampen AH, ten Kate FJ et al. Gene expression in early stage cervical cancer. Gynecol Oncol 2008; 108: 520-526.
11. Cheng Y, Jin Z, Agarwal R, Ma K, Yang J, Ibrahim S et al. LARP7 is a potential tumor suppressor gene in gastric cancer. Lab Invest 2012; 92: 1013-1019.
12. Blagden SP, Gatt MK, Archambault V, Lada K, Ichihara K, Lilley KS et al. Drosophila Larp associates with poly(A)-binding protein and is required for male fertility and syncytial embryo development. Dev Biol 2009; 334: 186-197.
13. Aoki K, Adachi S, Homoto M, Kusano H, Koike K, Natsume T. LARP1 specifically recognizes the 3? terminus of poly(A) mRNA. FEBS Lett 2013; 587: 2173-2178.
14. Tcherkezian J, Cargnello M, Romeo Y, Huttlin EL, Lavoie G, Gygi SP et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5'TOP mRNA translation. Genes Dev 2014; 28: 357-371.
15. Hsu PP, Kang SA, Rameseder J, Zhang Y, Ottina KA, Lim D et al. The mTORregulated phosphoproteome reveals a mechanism of mTORC1-mediated inhibition of growth factor signaling. Science 2011; 332: 1317-1322.
16. Yu Y, Yoon SO, Poulogiannis G, Yang Q, Ma XM, Villen J et al. Phosphoproteomic analysis identifies Grb10 as an mTORC1 substrate that negatively regulates insulin signaling. Science 2011; 332: 1322-1326.
17. Dhillon T, Mauri FA, Bellezza G, Cagini L, Barbareschi M, North BV et al. Overexpression of the mammalian target of rapamycin: a novel biomarker for poor survival in resected early stage non-small cell lung cancer. J Thorac Oncol 2010; 5: 314-319.
18. Liu D, Huang Y, Chen B, Zeng J, Guo N, Zhang S et al. Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma. Cancer 2011; 117: 3763-3773.
19. Molinolo AA, Marsh C, El Dinali M, Gangane N, Jennison K, Hewitt S et al. mTOR as a molecular target in HPV-associated oral and cervical squamous carcinomas. Clin Cancer Res 2012; 18: 2558-2568.
20. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D et al. ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 2004; 6: 1-6.
21. Iwakawa M, Ohno T, Imadome K, Nakawatari M, Ishikawa K, Sakai M et al. The radiation-induced cell-death signaling pathway is activated by concurrent use of cisplatin in sequential biopsy specimens from patients with cervical cancer. Cancer Biol Ther 2007; 6: 905-911.
22. Gyorffy B, Surowiak P, Budczies J, Lanczky A. Online survival analysis software to assess the prognostic value of biomarkers using transcriptomic data in non-smallcell lung cancer. PLoS ONE 2013; 8: e82241.
23. Mukherjee N, Corcoran DL, Nusbaum JD, Reid DW, Georgiev S, Hafner M et al. Integrative regulatory mapping indicates that the RNA-binding protein HuR couples pre-mRNA processing and mRNA stability. Mol Cell 2011; 43: 327-339.
24. Chen CY, Xu N, Shyu AB. mRNA decay mediated by two distinct AU-rich elements from c-fos and granulocyte-macrophage colony-stimulating factor transcripts: different deadenylation kinetics and uncoupling from translation. Mol Cell Biol 1995; 15: 5777-5788.
25. Graham JR, Hendershott MC, Terragni J, Cooper GM. mRNA degradation plays a significant role in the program of gene expression regulated by phosphatidylinositol 3-kinase signaling. Mol Cell Biol 2010; 30: 5295-5305.
26. Matoulkova E, Michalova E, Vojtesek B, Hrstka R. The role of the 3? untranslated region in post-transcriptional regulation of protein expression in mammalian cells. RNA Biol 2012; 9: 563-576.
27. Hsieh AC, Liu Y, Edlind MP, Ingolia NT, Janes MR, Sher A et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 2012; 485: 55-61.
28. Wang MJ, Pei DS, Qian GW, Yin XX, Cheng Q, Li LT et al. p53 regulates Ki-67 promoter activity through p53-and Sp1-dependent manner in HeLa cells. Tumour Biol 2011; 32: 905-912.
29. Lukong KE, Chang KW, Khandjian EW, Richard S. RNA-binding proteins in human genetic disease. Trends Genet 2008; 24: 416-425.
30. Wurth L. Versatility of RNA-binding proteins in cancer. Comp Funct Genomics 2012; 2012: 178525.
31. Zaytseva YY, Valentino JD, Gulhati P, Evers BM. mTOR inhibitors in cancer therapy. Cancer Lett 2012; 319: 1-7.
32. Nagaraja AK, Creighton CJ, Yu Z, Zhu H, Gunaratne PH, Reid JG et al. A link between mir-100 and FRAP1/mTOR in clear cell ovarian cancer. Mol Endocrinol 2010; 24: 447-463.
33. Xu C, Zeng Q, Xu W, Jiao L, Chen Y, Zhang Z et al. miRNA-100 inhibits human bladder urothelial carcinogenesis by directly targeting mTOR. Mol Cancer Ther 2013; 12: 207-219.
34. Burrows C, Abd Latip N, Lam SJ, Carpenter L, Sawicka K, Tzolovsky G et al. The RNA binding protein Larp1 regulates cell division, apoptosis and cell migration. Nucleic Acids Res 2010; 38: 5542-5553.
35. Bernstein P, Peltz SW, Ross J. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol 1989; 9: 659-670.
36. Mangus DA, Evans MC, Jacobson A. Poly(A)-binding proteins: multifunctional scaffolds for the post-transcriptional control of gene expression. Genome Biol 2003; 4: 223.
37. Chang N, Yi J, Guo G, Liu X, Shang Y, Tong T et al. HuR uses AUF1 as a cofactor to promote p16INK4 mRNA decay. Mol Cell Biol 2010; 30: 3875-3886.
38. Kim HH, Kuwano Y, Srikantan S, Lee EK, Martindale JL, Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes Dev 2009; 23: 1743-1748.
39. Merret R, Descombin J, Juan YT, Favory JJ, Carpentier MC, Chaparro C et al. XRN4 and LARP1 are required for a heat-triggered mRNA decay pathway involved in plant acclimation and survival during thermal stress. Cell Rep 2013; 5: 1279-1293.
40. Umayahara K, Numa F, Suehiro Y, Sakata A, Nawata S, Ogata H et al. Comparative genomic hybridization detects genetic alterations during early stages of cervical cancer progression. Genes Chromosomes Cancer 2002; 33: 98-102.
41. Shi SR, Key ME, Kalra KL. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J HistochemCytochem1991; 39: 741-748.
42. Keene JD, Komisarow JM, Friedersdorf MB. RIP-Chip: the isolation and identification of mRNAs, microRNAs and protein components of ribonucleoprotein complexes from cell extracts. Nat Protoc 2006; 1: 302-307.
43. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article 3.
44. Eswaran J, Horvath A, Godbole S, Reddy SD, Mudvari P, Ohshiro K et al. RNA sequencing of cancer reveals novel splicing alterations. Sci Rep 2013; 3: 1689.
45. Tibes R, Qiu Y, Lu Y, Hennessy B, Andreeff M, Mills GB et al. Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells. Mol Cancer Ther 2006; 5: 2512-2521.
46. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ et al. Guidelines for the welfare and use of animals in cancer research. Br J Cancer 2010; 102: 1555-1577.